Pulse Biosciences, Inc Common Stock (DE) (PLSE) Stock Price

PLSEStock

$44.43+152.87%52W

Market Cap$3.17B

P/E—

PEG Ratio—

Div yield—

Beta1.65

PLSE Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)110.92%

Price vs S&P 500 (4W)-15.33%

VGM Score42.33

Book Value / Share (Quarterly)$1.41

P/TBV (Annual)11.62x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)-20.63%

Cash Flow / Share (Quarterly)$-0.87

Price vs S&P 500 (YTD)211.67%

Gross Margin (TTM)0.25%

Net Profit Margin (TTM)-6755.78%

EPS (TTM)$-1.17

10-Day Avg Trading Volume0.40M

EPS Excl Extra (TTM)$-1.17

EPS (Annual)$-1.08

ROI (Annual)-90.24%

Gross Margin (Annual)-54.00%

Net Profit Margin (5Y Avg)-12111.99%

Cash / Share (Quarterly)$1.44

ROA (Last FY)-76.99%

EBITD / Share (TTM)$-1.21

ROE (5Y Avg)-125.64%

Operating Margin (TTM)-7007.76%

Cash Flow / Share (Annual)$-0.80

P/B Ratio32.46x

P/B Ratio (Quarterly)19.29x

Net Income / Employee (Annual)$-627,400

EV / Revenue (TTM)2640.13x

Net Interest Coverage (TTM)-129.02x

ROA (TTM)-79.96%

EPS Incl Extra (Annual)$-1.08

Current Ratio (Annual)10.53x

Quick Ratio (Quarterly)9.27x

3-Month Avg Trading Volume0.47M

52-Week Price Return152.87%

Revenue / Employee (TTM)$10,200

Tangible BV / Share (Quarterly)$1.40

P/S Ratio (Annual)9229.07x

Asset Turnover (Annual)0.00x

52-Week High$58.90

Operating Margin (5Y Avg)-12131.87%

EPS Excl Extra (Annual)$-1.08

CapEx CAGR (5Y)-5.31%

Tangible BV CAGR (5Y)25.05%

26-Week Price Return120.83%

Quick Ratio (Annual)10.22x

13-Week Price Return54.92%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)9.63x

Enterprise Value$3.13B

Asset Turnover (TTM)0.01x

Book Value / Share Growth (5Y)-4.23%

Revenue / Employee (Annual)$3,000

Inventory Turnover (Annual)4.10x

Pretax Margin (Annual)-20794.57%

Cash / Share (Annual)$1.19

3-Month Return Std Dev68.40%

Net Income / Employee (TTM)$-690,100

ROE (Last FY)-90.24%

Net Interest Coverage (Annual)-51.91x

EPS Basic Excl Extra (Annual)$-1.08

Receivables Turnover (TTM)23.33x

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$-1.17

Receivables Turnover (Annual)22.95x

ROI (TTM)-94.42%

P/S Ratio (TTM)2725.88x

Pretax Margin (5Y Avg)-12111.99%

Revenue / Share (Annual)$0.01

Tangible BV / Share (Annual)$1.18

Price vs S&P 500 (52W)137.34%

Year-to-Date Return223.60%

5-Day Price Return-15.29%

EPS Normalized (Annual)$-1.08

ROA (5Y Avg)-76.26%

Net Profit Margin (Annual)-20794.57%

Month-to-Date Return-11.00%

Cash Flow / Share (TTM)$-0.90

EBITD / Share (Annual)$-1.14

Operating Margin (Annual)-21982.57%

LT Debt / Equity (Annual)0.00x

ROI (5Y Avg)-125.20%

LT Debt / Equity (Quarterly)0.00x

EPS Basic Excl Extra (TTM)$-1.17

P/TBV (Quarterly)19.33x

P/B Ratio (Annual)11.54x

Inventory Turnover (TTM)8.24x

Pretax Margin (TTM)-6755.78%

Book Value / Share (Annual)$1.19

Price vs S&P 500 (13W)52.23%

Beta1.65x

Revenue / Share (TTM)$0.02

ROE (TTM)-94.42%

52-Week Low$12.56

vGradeF

mGradeA

vgmGradeC

PLSE Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 6, 2026	-$0.28	-$0.28	+1.47%(+$0.00)
Q1 2026	May 4, 2026	-$0.22	-$0.24	-9.73%(-$0.02)
Q4 2025	Feb 19, 2026	-$0.21	-$0.18	+14.27%(+$0.03)
Q3 2025	Nov 5, 2025	-$0.31	-$0.29	+6.45%(+$0.02)
Q2 2025	Aug 12, 2025	-$0.26	-$0.28	-7.69%(-$0.02)

PLSE Analyst Recommendations

Jun 2026

Jul 2026

Aug 2026

Sep 2026

4.25

4.22

4.20

Industry Peers — Surgical & Medical Instruments(142)

Symbol	Value Score	Growth Score	Momentum Score	P/S Ratio (TTM)	Revenue Growth (5Y)	Gross Margin (TTM)	Operating Margin (TTM)	Price
PLSEPulse Biosciences, Inc Common Stock (DE)	F	—	A	2725.9x	—	0.3%	-7007.8%	$44.43
SYKStryker Corporation	C	B	C	4.4x	11.8%	65.3%	21.3%	$294.66
MMM3M Company	C	D	B	3.4x	-5.0%	39.4%	18.4%	$164.75
BSXBoston Scientific Corp.	C	B	C	3.1x	15.2%	69.5%	19.8%	$44.39
BDXBecton, Dickinson and Co.	B	D	A	2.5x	6.3%	46.7%	9.6%	$191.75
MDLNMedline Inc. Class A common stock	C	D	C	1.6x	—	26.2%	6.0%	$35.96
RMDResMed Inc.	C	C	B	5.9x	12.1%	61.1%	33.4%	$238.97
DXCMDexCom, Inc.	C	B	B	6.5x	19.3%	64.3%	22.9%	$86.04
WSTWest Pharmaceutical Services, Inc.	D	C	A	8.5x	7.4%	36.8%	20.4%	$384.02
SOLVSolventum Corporation	C	C	B	1.8x	—	54.8%	23.9%	$85.81
BAXBaxter International Inc.	B	D	B	1.1x	-0.8%	30.7%	-2.3%	$25.28
PENPenumbra, Inc.	F	C	B	8.4x	20.2%	67.8%	12.4%	$320.86
GMEDGLOBUS MEDICAL INC	B	B	B	3.3x	30.1%	68.5%	20.6%	$76.71
PODDInsulet Corporation	C	A	C	3.2x	24.5%	71.1%	16.9%	$141.10
GKOSGlaukos Corporation	F	A	B	15.9x	17.7%	79.1%	-31.6%	$164.84
TFXTeleflex Incorporated	B	F	B	2.1x	-4.7%	53.8%	-11.7%	$130.43
HAEHaemonetics Corporation	C	C	A	4.0x	8.9%	59.1%	11.9%	$118.28
MMSIMerit Medical Systems Inc	C	B	B	3.4x	9.5%	49.5%	12.8%	$89.20
STVNStevanato Group S.p.A.	D	C	C	3.7x	12.4%	29.9%	16.4%	$18.90
MMEDMiniMed Group, Inc. Common Stock	—	—	B	—	—	—	—	$17.49
HTFLHeartflow, Inc. Common Stock	F	A	A	19.8x	—	80.1%	-40.8%	$48.29
ICUIICU Medical Inc	C	D	B	1.9x	11.9%	39.1%	3.5%	$162.99
IRTCiRhythm Holdings, Inc. Common Stock	D	B	C	4.3x	23.0%	71.5%	-3.0%	$108.66
ATRCAtriCure, Inc.	D	B	A	5.0x	20.9%	76.3%	2.3%	$56.07
UFPTUFP Technologies Inc	C	B	A	3.6x	27.4%	28.5%	15.3%	$291.67
INSPInspire Medical Systems, Inc.	B	B	B	2.2x	51.2%	86.1%	6.0%	$68.79
LMATLeMaitre Vascular, Inc.	C	B	C	7.0x	14.0%	72.9%	29.5%	$80.82
NVCRNovoCure Limited Ordinary Shares	D	C	C	2.3x	5.8%	76.1%	-22.1%	$14.07
KMTSKestra Medical Technologies, Ltd. Common Stock	F	A	B	15.2x	—	53.9%	-140.4%	$27.24
ATECAlphatec Holdings, Inc.	D	B	C	2.0x	39.5%	70.8%	-7.5%	$10.46
DRTSAlpha Tau Medical Ltd. Ordinary Shares	—	—	B	—	—	—	—	$12.29
TNDMTandem Diabetes Care, Inc.	D	C	C	1.1x	15.3%	56.0%	-4.4%	$16.24
IRMDiRadimed Corporation	D	B	B	13.1x	21.4%	75.9%	31.9%	$88.27
AORTArtivion, Inc.	C	C	C	2.3x	11.8%	64.4%	2.9%	$21.78
IARTIntegra LifeSciences Holdings	B	F	C	0.6x	3.6%	57.2%	4.0%	$13.21
PRCTPROCEPT BioRobotics Corporation Common Stock	C	A	D	3.0x	109.0%	64.2%	-33.9%	$17.57
BVSBioventus Inc. Class A Common Stock	B	C	A	1.9x	12.1%	68.7%	10.0%	$13.30
BBNXBeta Bionics, Inc. Common Stock	D	A	C	7.4x	—	58.3%	-69.8%	$16.35
SIBNSI-BONE, Inc. Common Stock	D	B	B	4.1x	22.3%	79.5%	-8.3%	$19.68
SGPSpyGlass Pharma, Inc. Common Stock	—	—	B	—	—	—	—	$24.00
MDXGMiMedx Group, Inc	C	D	C	1.8x	11.0%	78.8%	2.5%	$4.43
KIDSOrthoPediatrics Corp. Common Stock	C	B	B	2.3x	27.2%	73.7%	-11.9%	$21.95
TCMDTactile Systems Technology, Inc.	B	B	B	1.5x	12.0%	51.9%	10.0%	$22.52
SSIISS Innovations International Inc. Common Stock	F	A	D	9.7x	—	47.6%	-16.2%	$2.53
DCTHDelcath Systems Inc	D	C	B	5.1x	120.1%	87.0%	-1.9%	$14.08
ANGOAngioDynamics, Inc.	C	D	C	1.5x	1.9%	55.6%	-11.2%	$11.24
BWAYBrainsway Ltd. American Depositary Shares	D	B	B	9.5x	12.2%	74.9%	5.8%	$11.44
SGHTSight Sciences, Inc. Common Stock	D	B	A	5.5x	22.9%	88.4%	-33.4%	$8.28
CERSCerus Corp	D	C	C	1.8x	15.4%	57.2%	-0.7%	$2.18
NPCENeuropace, Inc. Common Stock	D	C	C	4.3x	19.4%	79.6%	-15.3%	$12.24
RCELAvita Medical, Inc. Common Stock	D	C	A	5.3x	19.6%	82.1%	-46.6%	$13.04

About Pulse Biosciences, Inc Common Stock (DE)

Pulse Biosciences develops Nano-Pulse Stimulation (NPS), a proprietary bioelectric medicine technology that uses precise nanosecond electrical pulses to remove diseased cells while preserving surrounding healthy tissue. The platform addresses multiple medical indications where current treatment options are insufficient or suboptimal. NPS represents a potentially transformative approach for treating conditions across various therapeutic areas.

PLSE Next Earnings Report

Report dateNov 5, 2026

QuarterQ3 2026

Report timeAMC

EPS estimate-$0.29

Revenue estimate$521,670

Also reporting on Nov 5, 2026

Scheduled date with consensus estimates — both can change before the company reports.

Earnings calendar for November 2026

Companies in Related Industries

MIRMirion Technologies, Inc.Measuring & Controlling Devices
NVSTEnvista Holdings Corporation Common stock, $0.01 par value per share
BMIBadger Meter, Inc.Fluid Meters
ITRIItron IncInstruments for Measuring
WRBYWarby Parker Inc.Ophthalmic Goods
IMAXImax CorpPhotographic Equipment & Supplies
TMDXTransMedics Group, Inc. Common StockElectromedical Equipment
COHUCohu IncInstruments for Measuring

Same SIC sector, outside this company's own industry.

Analyst Sentiment

4.2

Strong Buy

Consensus rating

52-Week Range

Low$12.56

High$58.90